228 related articles for article (PubMed ID: 24051421)
1. First cases of dominant optic atrophy in Saudi Arabia: report of two novel OPA1 mutations.
Galvez-Ruiz A; Neuhaus C; Bergmann C; Bolz H
J Neuroophthalmol; 2013 Dec; 33(4):349-53. PubMed ID: 24051421
[TBL] [Abstract][Full Text] [Related]
2. Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.
Yu-Wai-Man P; Shankar SP; Biousse V; Miller NR; Bean LJ; Coffee B; Hegde M; Newman NJ
Ophthalmology; 2011 Mar; 118(3):558-63. PubMed ID: 21036400
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.
Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF
Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570
[TBL] [Abstract][Full Text] [Related]
4. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect.
Thiselton DL; Alexander C; Morris A; Brooks S; Rosenberg T; Eiberg H; Kjer B; Kjer P; Bhattacharya SS; Votruba M
Hum Genet; 2001 Nov; 109(5):498-502. PubMed ID: 11735024
[TBL] [Abstract][Full Text] [Related]
5. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
[TBL] [Abstract][Full Text] [Related]
6. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.
Ferré M; Bonneau D; Milea D; Chevrollier A; Verny C; Dollfus H; Ayuso C; Defoort S; Vignal C; Zanlonghi X; Charlin JF; Kaplan J; Odent S; Hamel CP; Procaccio V; Reynier P; Amati-Bonneau P
Hum Mutat; 2009 Jul; 30(7):E692-705. PubMed ID: 19319978
[TBL] [Abstract][Full Text] [Related]
7. Structural model of the OPA1 GTPase domain may explain the molecular consequences of a novel mutation in a family with autosomal dominant optic atrophy.
Dadgar S; Hagens O; Dadgar SR; Haghighi EN; Schimpf S; Wissinger B; Garshasbi M
Exp Eye Res; 2006 Sep; 83(3):702-6. PubMed ID: 16698014
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
[TBL] [Abstract][Full Text] [Related]
9. Dominant optic atrophy.
Lenaers G; Hamel C; Delettre C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P; Milea D
Orphanet J Rare Dis; 2012 Jul; 7():46. PubMed ID: 22776096
[TBL] [Abstract][Full Text] [Related]
10. Dominant optic atrophy: correlation between clinical and molecular genetic studies.
Puomila A; Huoponen K; Mäntyjärvi M; Hämäläinen P; Paananen R; Sankila EM; Savontaus ML; Somer M; Nikoskelainen E
Acta Ophthalmol Scand; 2005 Jun; 83(3):337-46. PubMed ID: 15948788
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
[TBL] [Abstract][Full Text] [Related]
12. The natural history of OPA1-related autosomal dominant optic atrophy.
Cohn AC; Toomes C; Hewitt AW; Kearns LS; Inglehearn CF; Craig JE; Mackey DA
Br J Ophthalmol; 2008 Oct; 92(10):1333-6. PubMed ID: 18653586
[TBL] [Abstract][Full Text] [Related]
13. Dominant optic atrophy caused by a novel OPA1 splice site mutation (IVS20+1G-->A) associated with intron retention.
Hayashi T; Gekka T; Omoto S; Takeuchi T; Kitahara K
Ophthalmic Res; 2005; 37(4):214-24. PubMed ID: 16006781
[TBL] [Abstract][Full Text] [Related]
14. Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.
Baris O; Delettre C; Amati-Bonneau P; Surget MO; Charlin JF; Catier A; Derieux L; Guyomard JL; Dollfus H; Jonveaux P; Ayuso C; Maumenee I; Lorenz B; Mohammed S; Tourmen Y; Bonneau D; Malthièry Y; Hamel C; Reynier P
Hum Mutat; 2003 Jun; 21(6):656. PubMed ID: 14961560
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant optic atrophy with
Maeda-Katahira A; Nakamura N; Hayashi T; Katagiri S; Shimizu S; Ohde H; Matsunaga T; Kaga K; Nakano T; Kameya S; Matsuura T; Fujinami K; Iwata T; Tsunoda K
Mol Vis; 2019; 25():559-573. PubMed ID: 31673222
[TBL] [Abstract][Full Text] [Related]
16. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.
Lodi R; Tonon C; Valentino ML; Iotti S; Clementi V; Malucelli E; Barboni P; Longanesi L; Schimpf S; Wissinger B; Baruzzi A; Barbiroli B; Carelli V
Ann Neurol; 2004 Nov; 56(5):719-23. PubMed ID: 15505825
[TBL] [Abstract][Full Text] [Related]
17. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.
Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V
Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568
[TBL] [Abstract][Full Text] [Related]
18. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.
Cohn AC; Toomes C; Potter C; Towns KV; Hewitt AW; Inglehearn CF; Craig JE; Mackey DA
Am J Ophthalmol; 2007 Apr; 143(4):656-62. PubMed ID: 17306754
[TBL] [Abstract][Full Text] [Related]
19. Mutation spectrum and splicing variants in the OPA1 gene.
Delettre C; Griffoin JM; Kaplan J; Dollfus H; Lorenz B; Faivre L; Lenaers G; Belenguer P; Hamel CP
Hum Genet; 2001 Dec; 109(6):584-91. PubMed ID: 11810270
[TBL] [Abstract][Full Text] [Related]
20. A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network.
Grau T; Burbulla LF; Engl G; Delettre C; Delprat B; Oexle K; Leo-Kottler B; Roscioli T; Krüger R; Rapaport D; Wissinger B; Schimpf-Linzenbold S
J Med Genet; 2013 Dec; 50(12):848-58. PubMed ID: 24136862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
